Substrate-source flexibility of an exponential-fed perfusion process to produce plasmid DNA for use as leishmaniasis vaccine

References

• Gonzalez-Valdez J, Aguilar-Yanez JM, Benavides J, et al. DNA based vaccines offer improved vaccination supply for the developing world. J Chem Technol Biotechnol. 2013;88:979–982.
   Web of Science ®Google Scholar
• Schmeer M, Buchholz T, Schleef M. Plasmid DNA manufacturing for indirect and direct clinical applications. Hum Gene Ther. 2017;28:856–861.
   PubMed Web of Science ®Google Scholar
• Tregoning JS, Kinnear E. Using plasmids as DNA vaccines for infectious diseases. Microbiol Spectr. 2014;2869:1–16.
   Google Scholar
• Munguia-Soto R, Garcia-Rendon A, Garibay-Escobar A, et al. Segregated growth kinetics of Escherichia coli DH5-NH36 in exponential-fed perfusion culture for pDNA vaccine production. Biotechnol Appl Biochem. 2015;62:795–805.
   PubMed Web of Science ®Google Scholar
• Grunwald T, Ulbert S. Improvement of DNA vaccination by adjuvants and sophisticated delivery devices: vaccine-platforms for the battle against infectious diseases. Clin Exp Vaccine Res. 2015;4:1–10.
   PubMed Web of Science ®Google Scholar
• Abbink P, Larocca RA, De La Barrera RA, et al. Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys. Science. 2016;353:1129–1132.
   PubMed Web of Science ®Google Scholar
• Nakayama Y, Aruga A. Comparison of current regulatory status for gene-based vaccines in the U.S., Europe and Japan. Vaccines (Basel). 2015;3:186–202.
   PubMed Web of Science ®Google Scholar
• Goncalves GA, Bower DM, Prazeres DMF, et al. Rational engineering of Escherichia coli strains for plasmid biopharmaceutical manufacturing. Biotechnol J. 2012;7:251–261.
   PubMed Web of Science ®Google Scholar
• Cheng L, Sun XM, Yi XP, et al. Large-scale plasmid preparation for transient gene expression. Biotechnol Lett. 2011;33:1559–1564.
   PubMed Web of Science ®Google Scholar
• Bohle K, Ross A. Plasmid DNA production for pharmaceutical use: role of specific growth rate and impact on process design. Biotechnol Bioeng. 2011;108:2099–2106.
   PubMed Web of Science ®Google Scholar
• de Almeida L, Fujimura AT, Del Cistia ML, et al. Nanotechnological strategies for treatment of leishmaniasis – a review. J Biomed Nanotechnol. 2017;13:117–133.
   PubMed Web of Science ®Google Scholar
• Hotez PJ, Bottazzi ME, Strych U. New vaccines for the world's poorest people. Annu Rev Med. 2016;67:405–417.
   PubMed Web of Science ®Google Scholar
• Walker DM, Oghumu S, Gupta G, et al. Mechanisms of cellular invasion by intracellular parasites. Cell Mol Life Sci. 2014;71:1245–1263.
   PubMed Web of Science ®Google Scholar
• Jain K, Jain NK. Vaccines for visceral leishmaniasis: a review. J Immunol Methods. 2015;422:1–12.
   PubMed Web of Science ®Google Scholar
• Kedzierski L. Leishmaniasis. Hum Vaccin. 2011;7:1204–1214.
   PubMed Web of Science ®Google Scholar
• Carrillo E, Fernandez L, Ibarra-Meneses AV, et al. F1 domain of the Leishmania (Leishmania) donovani nucleoside hydrolase promotes a Th1 response in Leishmania (Leishmania) infantum cured patients and in asymptomatic individuals living in an endemic area of leishmaniasis. Front Immunol. 2017;8:1–13.
   PubMed Web of Science ®Google Scholar
• Nagill R, Kaur S. Vaccine candidates for leishmaniasis: a review. Int Immunopharmacol. 2011;11:1464–1488.
   PubMed Web of Science ®Google Scholar
• Wunderlich M, Taymaz-Nikerel H, Gosset G, et al. Effect of growth rate on plasmid DNA production and metabolic performance of engineered Escherichia coli strains. J Biosci Bioeng. 2014;117:336–342.
   PubMed Web of Science ®Google Scholar
• Mahut M, Gargano A, Schuchnigg H, et al. Chemoaffinity material for plasmid DNA analysis by high-performance liquid chromatography with condition-dependent switching between isoform and topoisomer selectivity. Anal Chem. 2013;85:2913–2920.
   PubMed Web of Science ®Google Scholar
• Urthaler J, Schuchnigg H, Garidel P, et al. Industrial manufacturing of plasmid-DNA products for gene vaccination and therapy. In: Thalhamer J, Weisss R, Scheiblhofer S, editors. Gene vaccines. New York: Springer-Verlag/Wein; 2012. p. 311–330.
   Google Scholar
• Tejeda-Mansir A, Montesinos RM. Upstream processing of plasmid DNA for vaccine and gene therapy applications. Recent Patents Biotechnol. 2008;2:156–172.
   PubMedGoogle Scholar
• Yang JL, Yang Y. Plasmid size can affect the ability of Escherichia coli to produce high-quality plasmids. Biotechnol Lett. 2012;34:2017–2022.
   PubMed Web of Science ®Google Scholar
• Goncalves GA, Prather KLJ, Monteiro GA, et al. Plasmid DNA production with Escherichia coli GALG20, a pgi-gene knockout strain: fermentation strategies and impact on downstream processing. J Biotechnol. 2014;186:119–127.
   PubMed Web of Science ®Google Scholar
• O'Kennedy RD, Ward JM, Keshavarz-Moore E. Effects of fermentation strategy on the characteristics of plasmid DNA production. Biotechnol Appl Biochem. 2003;37:83–90.
   PubMed Web of Science ®Google Scholar
• Islas-Lugo F, Vega-Estrada J, Alvis CA, et al. Developing strategies to increase plasmid DNA production in Escherichia coli DH5 alpha using batch culture. J Biotechnol. 2016;233:66–73.
   PubMed Web of Science ®Google Scholar
• Phue JN, Lee SJ, Trinh L, et al. Modified Escherichia coli B (BL21), a superior producer of plasmid DNA compared with Escherichia coli K (DH5alpha)). Biotechnol Bioeng. 2008;101:831–836.
   PubMed Web of Science ®Google Scholar
• Silva F, Queiroz JA, Domingues FC. Plasmid DNA fermentation strategies: influence on plasmid stability and cell physiology. Appl Microbiol Biotechnol. 2012;93:2571–2580.
   PubMed Web of Science ®Google Scholar
• Garcia-Rendon A, Munguia-Soto R, Montesinos-Cisneros RM, et al. Performance analysis of exponential-fed perfusion cultures for pDNA vaccines production. J Chem Technol Biotechnol. 2017;92:342–349.
   Web of Science ®Google Scholar
• Bagnato G, Iulianelli A, Sanna A, et al. Glycerol production and transformation: a critical review with particular emphasis on glycerol reforming reaction for producing hydrogen in conventional and membrane reactors. Membranes. 2017;7:17–31.
   Web of Science ®Google Scholar
• Grunzel P, Pilarek M, Steinbruck D, et al. Mini-scale cultivation method enables expeditious plasmid production in Escherichia coli. Biotechnol J. 2014;9:128–136.
   PubMed Web of Science ®Google Scholar
• Sanchez-Casco M, Dumonteil E, Ortega-López J. Production optimisation of a DNA vaccine against leishmanaisis in flask culture. Afr J Biotechnol. 2013;12:4874–4880.
   Google Scholar
• Diogo MM, Queiroz JA, Prazeres DMF. Assessment of purity and quantification of plasmid DNA in process solutions using high-performance hydrophobic interaction chromatography. J Chromatogr A. 2003;998:109–117.
   PubMed Web of Science ®Google Scholar
• Carnes AE. Fermentation design for manufacturing of therapeutic plasmid DNA. Bioprocess Int. 2005;3:36–42.
   Google Scholar
• Carnes AE, Williams JA. Plasmid fermentation process for DNA immunization applications. Methods Mol Biol. 2014;1143:197–217.
   PubMedGoogle Scholar
• Ruíz O, Pérez M, Pupo M, et al. High cell density culture to produce pDNA for gene therapy in E. coli. Biopharm Int. 2009;22:40–45.
   Web of Science ®Google Scholar
• Carnes AE, Hodgson CP, Williams JA. Inducible Escherichia coli fermentation for increased plasmid DNA production. Biotechnol Appl Biochem. 2006;45:155–166.
   PubMed Web of Science ®Google Scholar
• de Almeida A, Giordano AM, Nikel PI, et al. Effects of aeration on the synthesis of poly(3-hydroxybutyrate) from glycerol and glucose in recombinant Escherichia coli. Appl Environ Microbiol. 2010;76:2036–2040.
   PubMed Web of Science ®Google Scholar
• Hempfling WP, Mainzer SE. Effects of varying the carbon source limiting growth on yield and maintenance characteristics of Escherichia coli in continuous culture. J Bacteriol. 1975;123:1076–1087.
   PubMed Web of Science ®Google Scholar
• Koch V, Ruffer HM, Schugerl K, et al. Effect of antifoam agents on the medium and microbial cell properties and process performance in small and large reactors. Process Biochem. 1995;30:435–446.
   Web of Science ®Google Scholar
• Morao A, Maia CI, da Fonseca MMR, et al. Effect of antifoam addition on gas-liquid mass transfer in stirred fermenters. Bioprocess Eng. 1999;20:165–172.
   Google Scholar